Clik here to view.
The U.S. Food and Drug Administration approved Ofev (nintedanib) for the...
Nintedanib FDA approves Ofev to treat idiopathic pulmonary fibrosis 10/15/2014 The U.S. Food and Drug Administration today approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis...
View ArticleClik here to view.
System Suitability for USP Chromatographic Methods
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: System Suitability for USP Chromatographic Methods How should system suitability tests (SSTs) be structured for USP monographs? More about...
View ArticleClik here to view.
Advanced Intermediate Flow Studies: Nevirapine
Originally posted on SynthFlow: After looking through a number of flow articles that describe and illustrate processes toward the production of drug final products and advanced intermediates, I...
View ArticleClik here to view.
USV Limited , WO 2014167577 Synthesis of dabigatran….NEW PATENT FEATURE ON...
USV Limited http://www.usvindia.com/ 16-Oct-2014 pub date WO-2014167577-A2 PATENT FEATURE ON THIS BLOG Title of the invention: “”SYNTHESIS OF DABIGATRAN”.” Applicants: USV LIMITED (IN)....
View ArticleClik here to view.
DRUG SPOTLIGHT…MONTELUKAST
MONTELUKAST MK-0476 (Montelukast, L-706631) US 8,007,830, US 5,565,473*PED, MERCK Pat exp…Aug 3, 2012 NPP Mar 26, 2015 NPP=new patient population exclusivity...
View ArticleClik here to view.
PRANLUKAST
PRANLUKAST Antiasthmatic. Benzamide, N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)- N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide...
View ArticleClik here to view.
Unanimous FDA panel support for Novartis’ secukinumab
Unanimous FDA panel support for Novartis’ secukinumab October 21, 2014 Kevin Grogan Advisors to the US Food and Drug Administration have voted unanimously to support approval of Novartis’ secukinumab...
View ArticleClik here to view.
Celgene oral Crohn’s drug GED-0301, Mongersen impresses in Phase II
Nogra制药，Celgene Nogra Pharma Limited 公司寡核苷酸（Oligonucleotides） 克罗恩病（Crohn’s disease） Shares in Celgene Corp have risen steadily following promising mid-stage data of its closely-watched Crohn’s disease...
View ArticleClik here to view.
What is a Drug Master File? by DR ANTHONY MELVIN CRASTO… An introduction with...
What is a Drug Master File? DR ANTHONY MELVIN CRASTO An introduction with case study of an API ……………. DMF by Anthony Crasto from ANTHONY MELVIN CRASTO Ph.D worlddrugtracker Filed under: Uncategorized...
View ArticleClik here to view.
FLOW SYNTHESIS IN ACTION
Multi-step synthesis using modular flow reactors: the preparation of yne-ones and their use in heterocycle synthesis I.R. Baxendale, S.C. Schou, J. Sedelmeier, S.V. Ley, Chem. Eur. J. 2010, 16,...
View ArticleClik here to view.
Piecing together the puzzle: understanding a mild, metal free reduction...
Originally posted on ORGANIC CHEMISTRY SELECT: Piecing together the puzzle: understanding a mild, metal free reduction method for large scale synthesis of hydrazines D.L. Browne,* I.R. Baxendale, S.V....
View ArticleClik here to view.
Ibudilast
IBUDILAST AV-411 KC-404 MN-166 2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one KYORIN Kyorin Seiyaku Kk……….INNOVATOR Properties: Crystals from hexane, mp 53.5-54°. Slightly sol in...
View ArticleClik here to view.
NDA, ANDA AND IND by DR ANTHONY CRASTO
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: NDA, ANDA AND IND by DR ANTHONY CRASTO ………. NDA ANDA IND by Anthony Crasto from ANTHONY MELVIN CRASTO Ph.D worlddrugtracker View...
View ArticleClik here to view.
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto from ANTHONY MELVIN...
View ArticleClik here to view.
ROFECOXIB
ROFECOXIB MK-966, MK-0966, Vioxx 162011-90-7 C17-H14-O4-S 314.3596 \ Percent Composition: C 64.95%, H 4.49%, O 20.36%, S 10.20% LitRef: Selective cyclooxygenase-2 (COX-2) inhibitor. Prepn: Y. Ducharme...
View ArticleClik here to view.
Continuous Flow Ligand-Free Heck Reactions Using Monolithic Pd[0] Nanoclusters
Continuous Flow Ligand-Free Heck Reactions Using Monolithic Pd[0] Nanoclusters N. Nikbin, M. Ladlow, S.V. Ley, Org. Proc. Res. Dev., 2007, 11, 458-462. http://pubs.acs.org/doi/abs/10.1021/op7000436...
View ArticleClik here to view.
A Microcapillary Flow Disc (MFD) Reactor for Organic Synthesis
A Microcapillary Flow Disc (MFD) Reactor for Organic Synthesis, C.H. Hornung, M.R. Mackley, I.R. Baxendale and S.V. Ley and, Org. Proc. Res. Dev., 2007, 11, 399-405....
View ArticleClik here to view.
Optimisation of Conditions for O-Benzyl and N-Benzyloxycarbonyl Protecting...
Optimisation of Conditions for O-Benzyl and N-Benzyloxycarbonyl Protecting Group Removal using an Automated Flow Hydrogenator K.R. Knudsen, J. Holden, S.V. Ley and M. Ladlow, Adv. Syn. Cat. 2007, 349,...
View ArticleClik here to view.
Cordyceps – Rare parasitic fungi could have anti-flammatory benefits
Originally posted on Clinicalnews.org: 19 Nov 2012 Caterpillar fungi (Cordyceps) are rare parasites found on hibernating caterpillars in the mountains of Tibet. For centuries they have been highly...
View ArticleClik here to view.
Prefacing the e-Book Epilogue: Metabolic Genomics and Pharmaceutics
Originally posted on Leaders in Pharmaceutical Business Intelligence: Prefacing the e-Book Epilogue: Metabolic Genomics and Pharmaceutics Author and Curator: Larry H. Bernstein, MD, FCAP Adieu, adieu,...
View Article